1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)pent-1-en-3-ol
| Common Name: |
1-(2,6,6-Trimethyl-1-cyclohexen-1-yl)pent-1-en-3-ol |
| IUPAC Name: |
(E)-1-(2,6,6-trimethylcyclohexen-1-yl)pent-1-en-3-ol |
| Molecular Formula: |
C14H24O |
| SMILES: |
CCC(C=CC1=C(CCCC1(C)C)C)O |
| Inchi: |
1S/C14H24O/c1-5-12(15)8-9-13-11(2)7-6-10-14(13,3)4/h8-9,12,15H,5-7,10H2,1-4H3/b9-8+ |
| Inchi Key: |
DZSNHSUUMHDJRJ-CMDGGOBGSA-N |
| Cas No: |
93840-90-5 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
208.34 |
| Mass (g/mol) |
208.183 |
| Molar Refractivity |
67.25 |
| Net Charge |
|
| HBD |
1 |
| HBA |
1 |
| Rt Bonds |
3 |
| Rings |
1 |
| TPSA |
20.23 |
| Hetero Atoms |
1 |
| Heavy Atoms |
15 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
298.00 to 299.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.000127 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.71 |
| LogP |
3.84 |
| iLOGP |
3.19 |
| XLOGP3 |
3.43 |
| WLOGP |
3.84 |
| MLOGP |
3.30 |
| ESOL Log S |
-3.09 |
| ESOL Solubility (mg/ml) |
0.168 |
| ESOL Solubility (mol/l) |
0.001 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-3.54 |
| Ali Solubility (mg/ml) |
0.06 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-3.03 |
| Silicos-IT Solubility (mg/ml) |
0.2 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.14 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
1.098 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.295 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
1 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
0 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
